Insider · CIK 0001376355
Jay Lichter
Files at JANX (Janux Therapeutics, Inc.). First filing Oct 24, 2024, latest Oct 24, 2024.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
JANX: Janux Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 19Weak | JANXsell Janux Therapeutics, Inc. | $178k 3,815 shares | -35% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 13, 2024 | JANX Janux Therapeutics, Inc. | MOption exercise Common Stock | +1,868 | $17.00 | $32k | 8,868 | Oct 24, 2024 |
| Sep 13, 2024 | JANX Janux Therapeutics, Inc. | MOption exercise Common Stock | +778 | $10.73 | $8,348 | 9,646 | Oct 24, 2024 |
| Sep 13, 2024 | JANX Janux Therapeutics, Inc. | MOption exercise Common Stock | +778 | $13.22 | $10k | 10,424 | Oct 24, 2024 |
| Sep 13, 2024 | JANX Janux Therapeutics, Inc. | MOption exercise Common Stock | +391 | $39.80 | $16k | 10,815 | Oct 24, 2024 |
| Sep 13, 2024 | JANX Janux Therapeutics, Inc. | SOpen-market sale Common Stock | -3,815 | $46.68 | $178k | 7,000 | Oct 24, 2024 |
| Sep 13, 2024 | JANX Janux Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative | -1,868 | $0.00 | $0 | 27,138 | Oct 24, 2024 |
| Sep 13, 2024 | JANX Janux Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative | -778 | $0.00 | $0 | 11,308 | Oct 24, 2024 |
| Sep 13, 2024 | JANX Janux Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative | -778 | $0.00 | $0 | 11,308 | Oct 24, 2024 |
| Sep 13, 2024 | JANX Janux Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative | -391 | $0.00 | $0 | 7,682 | Oct 24, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.